Special paperA realistic clinical perspective of tamoxifen and endometrial carcinogenesis
References (75)
- et al.
Alternative mechanisms of action of anti-oestrogens
Breast Cancer Res Treat
(1994) Anonymous. IARC way of assessing tamoxifen causes unease
Lancet
(1996)- et al.
Cancer incidence in five continents
- et al.
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies
J Natl Cancer Inst
(1995) - et al.
Lack of genotoxicity of tamoxifen in human endometrium
Cancer Res
(1996) Pathology of endometrium treated with tamoxifen
J Clin Pathol
(1994)- et al.
Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer
J Natl Cancer Inst
(1993) - et al.
Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features
Gynecol Oncol
(1994) - et al.
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial and breast cancers
J Natl Cancer Inst
(1995)
What if tamoxifen (ICI 46,474) had been found to produce liver tumors in 1973?
Ann Oncol
(1995)
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
Lancet
(1994)
Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers
Cancer J Sci Am
(1996)
Endometrial changes in patients on tamoxifen
Lancet
(1995)
Adjuvant tamoxifen in postmenopausal women with axillary node positive breast cancer. An update
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths in 75000 women
Lancet
(1992)
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths in 75000 women
Lancet
(1992)
The pharmacology and clinical uses of tamoxifen
Pharmacol Ther
(1984)
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
N Engl J Med
(1992)
Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study
J Clin Oncol
(1994)
Should adjuvant tamoxifen therapy be stopped at 5 years?
Cancer J Sci Am
(1996)
Endocrine effects of tamoxifen in postmenopausal breast cancer patients
Tumori
(1984)
Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial
Tamoxifen and the uterus and endometrium
Lancet
(1989)
Tamoxifen in healthy premenopausal and postmenopausal women: different risks and benefits
J Natl Cancer Inst
(1994)
Tamoxifen and the uterus
Br J Med
(1994)
New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent
J Natl Cancer Inst
(1991)
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial
Breast Cancer Res Treat
(1994)
Breast cancer study initiated in Italy
J Natl Cancer Inst
(1992)
Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens
Cancer Treat Rep
(1985)
Gynecologic effects of tamoxifen and the association with endometrial carcinoma
Int J Gynecol Obstet
(1995)
Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats
Carcinogenesis
(1986)
Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens
Arch Toxicol
(1993)
The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat
Carcinogenesis
(1993)
Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats
Cancer Res
(1993)
DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumor formation
Carcinogenesis
(1995)
Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells
Carcinogenesis
(1992)
Induction of covalent DNA adducts in rodents by tamoxifen
Cancer Res
(1992)
Cited by (119)
Tertiary prevention: Implications for improving the quality of life of long-term survivors of cancer
2005, Seminars in Oncology NursingLong-term results of hysteroscopic resection of endometrial polyps in 367 patients. Role of associated endometrial resection
2005, Gynecologie Obstetrique et FertiliteOvarian cysts in tamoxifen-treated women with breast cancer
2005, European Journal of Obstetrics and Gynecology and Reproductive BiologyLH-RH agonists offer very good protection against the adverse gynaecological effects induced by tamoxifen
2004, European Journal of CancerEndometrial pathologies associated with postmenopausal tamoxifen treatment
2004, Gynecologic Oncology
Copyright © 1996 Published by Elsevier Ltd.